Group 1 - The company EuroEyes Netherlands, a wholly-owned subsidiary of 德视佳 (01846), plans to acquire FYEO Europe B.V. for a maximum consideration of approximately €145.8 million (around HKD 1.234 billion) [1] - The acquisition is expected to be completed by July 15, 2026, assuming a zero loss amount [1] - The target company specializes in refractive surgeries through laser treatments or lens implants and is a leading private refractive surgery platform in the Netherlands [1] Group 2 - The board believes the acquisition aligns with the company's strategic goals, as both entities are focused solely on refractive surgery and share a patient-centered approach [2] - The target group is positioned to continue its growth trajectory in the rapidly expanding Dutch market, leveraging favorable growth levers such as increasing direct market access and advancements in refractive surgery technology [2] - The acquisition is expected to enhance the company's market position, improve overall competitiveness, ensure long-term sustainability, and create value for the company and its shareholders [2]
德视佳(01846)拟斥巨资收购荷兰屈光手术领军企业FYEO Europe B.V. 2月27日复牌